Back to ENGNW
FCPM III SERVICES B.V. → ENGNW
FCPM III SERVICES B.V. ENGNW Position History
enGene Therapeutics Inc. • Healthcare
Quarters held
16
Latest value
$95K
Q3 2026
Peak value
$60.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $60.8M |
| Q4 2025 | $26.1M |
| Q4 2025 | $7.1M |
| Q4 2025 | $1.4M |
| Q1 2026 | $45.9M |
| Q1 2026 | $19.7M |
| Q1 2026 | $6.1M |
| Q1 2026 | $1.2M |
| Q2 2026 | $11.7M |
| Q2 2026 | $5M |
| Q2 2026 | $697K |
| Q2 2026 | $138K |
| Q3 2026 | $13.5M |
| Q3 2026 | $5.8M |
| Q3 2026 | $481K |
| Q3 2026 | $95K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $95K | 475.1K | — | — |
| Q3 2026 | $481K | 2.40M | — | — |
| Q3 2026 | $5.8M | 2.89M | — | — |
| Q3 2026 | $13.5M | 6.74M | — | — |
| Q2 2026 | $138K | 475.1K | — | — |
| Q2 2026 | $697K | 2.40M | — | — |
| Q2 2026 | $5M | 2.89M | — | — |
| Q2 2026 | $11.7M | 6.74M | — | — |
| Q1 2026 | $1.2M | 475.1K | — | — |
| Q1 2026 | $6.1M | 2.40M | — | — |
| Q1 2026 | $19.7M | 2.89M | — | — |
| Q1 2026 | $45.9M | 6.74M | — | — |
| Q4 2025 | $1.4M | 475.1K | — | — |
| Q4 2025 | $7.1M | 2.40M | — | — |
| Q4 2025 | $26.1M | 2.89M | — | — |
| Q4 2025 | $60.8M | 6.74M | — | — |
Other funds holding ENGNW
$43.1M
$39.7M
$39.7M
$39.5M
$35.8M
$32.5M
Other FCPM III SERVICES B.V. positions
NAMSW
$163.1MNEWAMSTERDAM PHARMA COMPANY
NAMSW
$159.6MNEWAMSTERDAM PHARMA COMPANY
NAMSW
$157.5MNEWAMSTERDAM PHARMA COMPANY
NAMSW
$148.8MNEWAMSTERDAM PHARMA COMPANY
NAMSW
$145.7MNEWAMSTERDAM PHARMA COMPANY
NAMSW
$130.2MNEWAMSTERDAM PHARMA COMPANY
MPLT
$115.6MMAPLIGHT THERAPEUTICS INC
NAMSW
$113MNEWAMSTERDAM PHARMA COMPANY